Anti-Inflammatory 3
Anti-Inflammatory
Lead Generation/OptimizationActive
Key Facts
About RayThera
RayThera is a private, preclinical-stage biotechnology company focused on small molecule drug discovery for immunological diseases. The company is led by a highly experienced founding team with a proven track record of building and exiting biotech ventures, including XinThera (acquired by Gilead) and FronThera. Backed by notable life science investors like Foresite Capital and OrbiMed, RayThera employs an efficient, expertise-driven model to advance its pipeline of anti-inflammatory candidates from lead generation through preclinical development.
View full company profileTherapeutic Areas
Other Anti-Inflammatory Drugs
| Drug | Company | Phase |
|---|---|---|
| Anti-Inflammatory 1 | RayThera | Lead Generation/Optimization |
| Anti-Inflammatory 2 | RayThera | Lead Generation/Optimization |